LETTMANN JASON purchased 43.3% of their position (92.23K shares) of ALX ONCOLOGY HOLDINGS INC on the open market
Open‑market purchase worth $99.4K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/18/2025ACC: 0001193125-25-207432
Director10% Owner
Since Jul 2020
+92.23K
Net shares
Net buyer
$99.4K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
92.23K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+21.07K
Price / share
$1.07
Trade value
$22.46K
% of position
9.9%
9/16/2025
212.89K→233.96K
Common Stock
Direct
Shares
+71.16K
Price / share
$1.08
Trade value
$76.89K
% of position
30.4%
9/17/2025
233.96K→305.12K
Total
Net shares
+92.23K
Net value
$99.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2025 | P · Purchase | +21.07K | $1.07 | $22.46K | 9.9% | 212.89K | 233.96K |
| Common Stock Direct | 9/17/2025 | P · Purchase | +71.16K | $1.08 | $76.89K | 30.4% | 233.96K | 305.12K |
| Total | +92.23K | $99.35K | ||||||
Derivative Transactions0
No derivative transactions reported